- Home
- RLAY vs USNA Comparison
RLAY vs USNA Comparison
Compare RLAY & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- USNA
- Stock Information
- Founded
- RLAY 2015
- USNA 1992
- Country
- RLAY United States
- USNA United States
- Employees
- RLAY N/A
- USNA N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- USNA Medicinal Chemicals and Botanical Products
- Sector
- RLAY Health Care
- USNA Health Care
- Exchange
- RLAY Nasdaq
- USNA Nasdaq
- Market Cap
- RLAY 490.3M
- USNA 541.4M
- IPO Year
- RLAY 2020
- USNA 1996
- Fundamental
- Price
- RLAY $3.18
- USNA $30.54
- Analyst Decision
- RLAY Strong Buy
- USNA Hold
- Analyst Count
- RLAY 11
- USNA 1
- Target Price
- RLAY $18.40
- USNA $36.00
- AVG Volume (30 Days)
- RLAY 1.5M
- USNA 134.4K
- Earning Date
- RLAY 08-05-2025
- USNA 07-22-2025
- Dividend Yield
- RLAY N/A
- USNA N/A
- EPS Growth
- RLAY N/A
- USNA N/A
- EPS
- RLAY N/A
- USNA 1.82
- Revenue
- RLAY $7,679,000.00
- USNA $876,242,000.00
- Revenue This Year
- RLAY $14.31
- USNA $13.04
- Revenue Next Year
- RLAY N/A
- USNA $7.36
- P/E Ratio
- RLAY N/A
- USNA $16.79
- Revenue Growth
- RLAY N/A
- USNA N/A
- 52 Week Low
- RLAY $1.78
- USNA $23.10
- 52 Week High
- RLAY $10.72
- USNA $48.85
- Technical
- Relative Strength Index (RSI)
- RLAY 55.48
- USNA 56.70
- Support Level
- RLAY $2.98
- USNA $29.29
- Resistance Level
- RLAY $3.48
- USNA $31.20
- Average True Range (ATR)
- RLAY 0.25
- USNA 0.74
- MACD
- RLAY -0.00
- USNA -0.00
- Stochastic Oscillator
- RLAY 58.45
- USNA 71.05
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About USNA USANA Health Sciences Inc.
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.